Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...
The diagnostics advisory committee reviewed the evidence available on the cost effectiveness of viscoelastometric testing to help detect, manage and monitor haemostasis in cardiac surgery and in the ...
BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback